Corey Seager and Josh Jung are candidates for offseason surgery, Rangers announce

What happened

Texas's two cornerstone infielders are facing the same uncomfortable offseason question. MLB.com reported that Corey Seager is a candidate for elbow surgery and Josh Jung is a candidate for hand surgery, with both procedures potentially affecting their availability at the start of next season. The Rangers announced the injury statuses through MLB.com, making this an organizational disclosure rather than a rumor circulating through the trade-deadline fog.

Neither surgery has been described as scheduled or completed. The word in the reporting is "candidate" — a clinical hedge that carries real weight. It means the medical conversation is open, the decision has not yet been made, and the timeline that follows that decision remains unwritten.

Why it matters

The Rangers finished 2026 at 80-82, eliminated from the Wild Card race and out of the division race, ending the year on a loss on the final day of the regular season, per Posterior reporting. Rangers GM Chris Young publicly acknowledged organizational shortcomings and pledged to address them, also per Posterior reporting. That is the backdrop against which two potential offseason surgeries land — not a team with margin to absorb uncertainty, but one already committed to some form of organizational reset heading into the winter.

Seager and Jung are not peripheral pieces. They are the middle of the Rangers' infield and, in Seager's case, the franchise's most prominent long-term investment. When both of them enter an offseason as surgical candidates, the club's planning window for next spring compresses in ways that affect roster construction, spring training preparation, and the realistic shape of the roster when the season opens.

The timing also matters in a mechanical sense. Offseason surgeries, depending on their scope and the recovery protocols that follow, can push a player's return into spring training, into the early regular season, or beyond. None of those specific timelines have been reported — the material says "candidate," and the desk will not fill in what the material leaves open.

Is Seager's availability for Opening Day in question?

That is precisely what remains unresolved. MLB.com's reporting frames both players as candidates for surgery, with availability at the start of next season described as potentially affected. No return date, no procedure date, and no surgical decision has been reported. The honest answer to the fan question is: yes, it is in question, and no, nobody has said how much.

What the reporting does establish is that the concern is real enough for the organization to disclose it publicly. Teams do not typically volunteer surgical candidacy for their franchise shortstop as a casual footnote.

The numbers

Seager's durability has been a recurring organizational concern. Posterior reporting noted that Seager missed 60 games for the second consecutive season in 2026 — a pattern that predates this latest elbow development and gives the current disclosure additional context. Two straight seasons of 60-game absences, and now a potential surgical procedure: the Rangers are not dealing with a new problem so much as a deepening one.

The club finished the 2026 season at 80-82 (.494), sitting 2nd in the AL West, 1 game back in the division, and ranked 4th in Wild Card positioning at 4.0 relative to the cut line. They enter the offseason having been eliminated from both races.

Where the club stands

Texas closed at 80-82 (.494), second in the AL West and 1 game back of the division lead, per the Posterior reporting. Their Wild Card rank was 4th, sitting 4.0 games relative to the cut line. They finished on a losing streak and were eliminated from both the division and Wild Card races.

That record, combined with the GM's public acknowledgment of organizational issues, sets the table for what figures to be an active and consequential offseason. The surgical candidacies of Seager and Jung do not simplify that work.

What we don't know yet

Neither surgery has been reported as scheduled. No procedure dates, no surgical decisions, and no recovery timelines have been disclosed. The reporting establishes candidacy — the possibility and apparent medical consideration of surgery — not a confirmed course of action for either player.

It is also not yet known how the Rangers plan to approach roster construction around these uncertainties. GM Chris Young's pledge to address organizational issues, per Posterior reporting, was made in a general context; no specific moves tied to Seager's or Jung's health have been reported.

What the club has done is put the information on the table. What they do with it next is the offseason story.

What to watch

The first thing to watch is whether either surgical decision gets made and announced. A "candidate" becomes a patient or doesn't, and that determination will set the practical timeline for each player's availability next spring. Any update from the Rangers' medical staff or front office on that front will be the next meaningful data point.

Beyond the individual health updates, watch how the Rangers approach the infield in free agency and trade discussions this winter. If one or both players are expected to miss time at the start of next season, the club's need for infield depth — and potentially infield starters — changes shape accordingly. Chris Young's stated commitment to fixing the team will be tested against a roster that may be missing two of its most important players when pitchers and catchers report.

The 2026 season ended with the Rangers on the outside of the postseason looking in. Seager and Jung are central to whatever the next chapter looks like. Right now that chapter has not started, and the two players most expected to anchor it are waiting on medical decisions that neither they nor the club have yet made.

The desk will update when the Rangers do.